{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:43:08Z","timestamp":1792662188275,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223499\/Z\/21\/Z"],"award-info":[{"award-number":["223499\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome Early-Career Award","award":["301005\/Z\/23\/Z"],"award-info":[{"award-number":["301005\/Z\/23\/Z"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>Large differences between glomerular filtration rate estimated with creatinine and cystatin C\u2014termed estimated glomerular filtration rate (eGFR) discordance\u2014have important implications for health. Several demographic factors and individual long-term conditions (LTCs) are associated with eGFR discordance. We hypothesize that the presence of multiple LTCs, i.e. multimorbidity is likely to be associated with eGFR discordance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differences between creatinine-based and cystatin C-based eGFR [eGFR using serum creatinine (eGFRcr) and eGFR using serum cystatin C (eGFRcys), respectively] using European Kidney Function Consortium equations were calculated in over 400\u2009000 UK Biobank participants. Large negative eGFR difference was defined as an eGFRcys &amp;gt;30% lower than eGFRcr, i.e. ([eGFRcys \u2212 eGFRcr]\/eGFRcr) &amp;lt; \u221230%. Self-reported LTCs were counted and analysed overall and by type of multimorbidity (cardiometabolic, non-cardiometabolic, mixed mental and physical). Proportions of participants with large negative eGFR differences were cross-tabulated at different chronic kidney disease (CKD) stages and according to number of LTCs. The association between number of LTCs and eGFR discordance was assessed in logistic regression models adjusted for age, sex, body mass index, smoking status, and thyroid disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multimorbidity (two or more LTCs of any type) was observed in 33% of the overall cohort and 63% of those with large negative eGFR differences. When CKD stage was assigned based on eGFRcr and then reassigned using eGFRcys, 15% of the cohort were reclassified to a more advanced CKD stage with frequency of reclassification increasing progressively with increasing counts of LTCs. Individuals with four or more LTCs of any type were more than four-fold more likely to have a large negative eGFR difference (adjusted odds ratio 4.64, 95% confidence interval 4.13\u20135.21) compared to individuals with no LTCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Discordance between creatinine-based and cystatin C-based eGFR increased substantially with multimorbidity. Cystatin C testing should be considered (alongside creatinine) in individuals with multimorbidity to refine estimation of kidney function and risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag232","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:46:18Z","timestamp":1791546378000},"source":"Crossref","is-referenced-by-count":0,"title":["Association between multimorbidity and discordance between creatinine- and cystatin C-based eGFR"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-0270","authenticated-orcid":false,"given":"Kaitlin J","family":"Mayne","sequence":"first","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Walker","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, University of Dundee , Dundee ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K","family":"Sullivan","sequence":"additional","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-514X","authenticated-orcid":false,"given":"Bhautesh","family":"Jani","sequence":"additional","affiliation":[{"name":"School of Health & Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-3643","authenticated-orcid":false,"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-3974","authenticated-orcid":false,"given":"Qiaoling","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Center for Kidney Diseases, The Second Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P","family":"Pell","sequence":"additional","affiliation":[{"name":"School of Health & Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick K","family":"Ho","sequence":"additional","affiliation":[{"name":"School of Health & Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-2123","authenticated-orcid":false,"given":"Patrick B","family":"Mark","sequence":"additional","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-0178","authenticated-orcid":false,"given":"Jennifer S","family":"Lees","sequence":"additional","affiliation":[{"name":"School of Cardiovascular & Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"2026102205285121600_bib1","doi-asserted-by":"publisher","first-page":"101860","DOI":"10.1016\/j.eclinm.2023.101860","article-title":"Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis","volume":"57","author":"Chowdhury","year":"2023","journal-title":"E Clinical Medicine"},{"key":"2026102205285121600_bib2","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.3399\/bjgp20X714125","article-title":"Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care","volume":"71","author":"MacRae","year":"2021","journal-title":"Br J Gen Pract"},{"key":"2026102205285121600_bib3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-022-02628-2","article-title":"The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function","volume":"20","author":"Sullivan","year":"2022","journal-title":"BMC Med"},{"key":"2026102205285121600_bib4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12916-021-02147-6","article-title":"Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings","volume":"19","author":"Sullivan","year":"2021","journal-title":"BMC Med"},{"key":"2026102205285121600_bib5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.34067\/KID.0003202022","article-title":"Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR","volume":"3","author":"Chen","year":"2022","journal-title":"Kidney360"},{"key":"2026102205285121600_bib6","doi-asserted-by":"publisher","first-page":"sfaf003","DOI":"10.1093\/ckj\/sfaf003","article-title":"Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis","volume":"18","author":"Liu","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026102205285121600_bib7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2025.17578","article-title":"Discordance in creatinine- and cystatin C-based eGFR and clinical outcomes: a meta-analysis","volume":"334","author":"Estrella","year":"2025","journal-title":"J Am Med Assoc"},{"key":"2026102205285121600_bib8","doi-asserted-by":"publisher","first-page":"e2321715","DOI":"10.1001\/jamanetworkopen.2023.21715","article-title":"Medication-related adverse events and discordancies in cystatin C-based vs serum creatinine-based estimated glomerular filtration rate in patients with cancer","volume":"6","author":"Hanna","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026102205285121600_bib9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7326\/M20-4366","article-title":"Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data","volume":"174","author":"Pottel","year":"2021","journal-title":"Ann Intern Med"},{"key":"2026102205285121600_bib10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa2203769","article-title":"Cystatin C-based equation to estimate GFR without the inclusion of race and sex","volume":"388","author":"Pottel","year":"2023","journal-title":"N Engl J Med"},{"key":"2026102205285121600_bib11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/ckj\/sfad039","article-title":"New and old GFR equations: a European perspective","volume":"16","author":"Delanaye","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026102205285121600_bib12","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ekir.2025.01.030","article-title":"Discordant results between creatinine- and cystatin C-based equations for estimating GFR","volume":"10","author":"Delanaye","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026102205285121600_bib13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","article-title":"The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine","volume":"37","author":"Elliott","year":"2008","journal-title":"Int J Epidemiol"},{"key":"2026102205285121600_bib14","article-title":"UK Biobank Biomarker Project Companion Document to Accompany Serum Biomarker Data","author":"Fry","year":"2019"},{"key":"2026102205285121600_bib15","article-title":"Blood Sample Collection, Processing and Transport","author":"UK Biobank","year":"2011"},{"key":"2026102205285121600_bib16","article-title":"UK Biobank Biomarker Panel","volume-title":"Date accessed 01 May 2026","author":"UK Biobank\u2019s Enhancements Working Group","year":"2015"},{"key":"2026102205285121600_bib17","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"KDIGO","year":"2024","journal-title":"Kidney Int"},{"key":"2026102205285121600_bib18","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026102205285121600_bib19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"2026102205285121600_bib20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12916-019-1305-x","article-title":"Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort","volume":"17","author":"Jani","year":"2019","journal-title":"BMC Med"},{"key":"2026102205285121600_bib21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ndt\/gfaf252","article-title":"The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks","volume":"41","author":"Walker","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"2026102205285121600_bib22","doi-asserted-by":"publisher","first-page":"100796","DOI":"10.1016\/j.xkme.2024.100796","article-title":"Cystatin C- and creatinine-based estimated GFR differences: prevalence and predictors in the UK Biobank","volume":"6","author":"Chen","year":"2024","journal-title":"Kidney Med"},{"key":"2026102205285121600_bib23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2215\/CJN.0000000000000217","article-title":"Discrepancies between cystatin C-based and creatinine-based eGFR","volume":"18","author":"Farrington","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026102205285121600_bib24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1053\/j.ajkd.2023.04.002","article-title":"Discordances between creatinine- and cystatin C-based estimated GFR and adverse clinical outcomes in routine clinical practice","volume":"82","author":"Carrero","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2026102205285121600_bib25","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"GBD 2023 Chronic Kidney Disease Collaborators","year":"2025","journal-title":"Lancet"},{"key":"2026102205285121600_bib26","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1681\/ASN.0000000000000128","article-title":"Accuracy of GFR estimating equations in patients with discordances between creatinine and cystatin C-based estimations","volume":"34","author":"Fu","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026102205285121600_bib27","doi-asserted-by":"publisher","first-page":"m131","DOI":"10.1136\/bmj.m131","article-title":"Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis","volume":"368","author":"Batty","year":"2020","journal-title":"BMJ"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag232\/71836867\/gfag232.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag232\/71836867\/gfag232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:28:58Z","timestamp":1792661338000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag232\/8907184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag232","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"article-number":"gfag232"}}